
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
Yuqing Shen, Hui Lin, Kelie Chen, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Yuqing Shen, Hui Lin, Kelie Chen, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
RIPK2: a promising target for cancer treatment
Jieqiong You, Yanru Wang, Haifeng Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Jieqiong You, Yanru Wang, Haifeng Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
RIPK2 inhibitors for disease therapy: Current status and perspectives
Erkang Tian, Changhan Zhou, Shuqi Quan, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115683-115683
Closed Access | Times Cited: 9
Erkang Tian, Changhan Zhou, Shuqi Quan, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115683-115683
Closed Access | Times Cited: 9
IP3R1 dysregulation via mir-200c-3p/SSFA2 axis contributes to taxol resistance in head and neck cancer
Fatma Şanli, Arzu Tatar, Betül Gündoğdu, et al.
European Journal of Pharmacology (2024) Vol. 973, pp. 176592-176592
Closed Access | Times Cited: 2
Fatma Şanli, Arzu Tatar, Betül Gündoğdu, et al.
European Journal of Pharmacology (2024) Vol. 973, pp. 176592-176592
Closed Access | Times Cited: 2
NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
Dongjie Wang
Computational Intelligence and Neuroscience (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 10
Dongjie Wang
Computational Intelligence and Neuroscience (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 10
QSAR analysis for pyrimidine and pyridine derivatives as RIPK2 (receptor interacting protein kinase 2) inhibitors
Garima, Sanjeev Sharma, Jayant Sindhu, et al.
Journal of the Indian Chemical Society (2023) Vol. 100, Iss. 8, pp. 101052-101052
Closed Access | Times Cited: 5
Garima, Sanjeev Sharma, Jayant Sindhu, et al.
Journal of the Indian Chemical Society (2023) Vol. 100, Iss. 8, pp. 101052-101052
Closed Access | Times Cited: 5
Development and Verification of Diagnosis Model for Papillary Thyroid Cancer Based on Pyroptosis-Related Genes: A Bioinformatic and in vitro Investigation
Lingling Ding, Guowan Zheng, Aimin Zhou, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 7761-7776
Open Access
Lingling Ding, Guowan Zheng, Aimin Zhou, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 7761-7776
Open Access
RIPK2 and lysosomal pathway: Unveiling a new mechanism for lung cancer metastasis
Wei Liu, Wei Xu, Huifang Hao, et al.
Translational Oncology (2024) Vol. 51, pp. 102182-102182
Closed Access
Wei Liu, Wei Xu, Huifang Hao, et al.
Translational Oncology (2024) Vol. 51, pp. 102182-102182
Closed Access